The Community Guide

- gsearch

Search Results

Narrow Results:

2024 1
2012 1

Journal Article 2

1 - 2 of 2 Results

Refine Results

Refine Results:

Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells

CITE Title : Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells Personal Author(s) : Klubo-Gwiezdzinska, Joanna;Jensen, Kirk;Costello, John;Patel, Aneeta;Hoperia, Victoria;Bauer, Andrew;Burman, Kenneth D;Wartofsky, Leonard;Vasko, Vasyl; Published Date : May 24 2012 Source : Endocr Relat Cancer. 19(3):447-456. URL : https://stacks.cdc.gov/view/cdc/58013 Klubo-Gwiezdzinska, Joanna et al. (2012). Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells. 19(3). Klubo-Gwiezdzinska, Joanna et al. "Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells" 19, no. 3 (2012) Klubo-Gwiezdzinska, Joanna et al. "Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells" vol. 19, no. 3, 2012 Export RIS Citation Information.

:

Klubo-Gwiezdzinska, Joanna ;

Jensen, Kirk

May 24 2012 | Endocr Relat Cancer. 19(3):447-456.

:

Medullary thyroid cancer (MTC) is associated with activation of mammalian target of rapamycin (mTOR) signaling pathways. Recent studies showed that th...
GEP NEC tumor spheroid drug screen reveals vulnerability to Tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors

CITE Title : GEP NEC tumor spheroid drug screen reveals vulnerability to Tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors Personal Author(s) : Beyer, Gabriella;Hueser, Sophia;Li, Rachel;Manika, Deeraj;Lee, Minhyuk;Chan, Carlos H.F.;Howe, James R.;Ear, Po Hien; Published Date : 3 2024;3-2024; Source : Surgery. 175(3):605-612 URL : https://stacks.cdc.gov/view/cdc/175222 Beyer, Gabriella et al. (2024). GEP NEC tumor spheroid drug screen reveals vulnerability to Tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors. 175(3). Beyer, Gabriella et al. "GEP NEC tumor spheroid drug screen reveals vulnerability to Tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors" 175, no. 3 (2024) Beyer, Gabriella et al. "GEP NEC tumor spheroid drug screen reveals vulnerability to Tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors" vol. 175, no. 3, 2024 Export RIS Citation Information.

:

Beyer, Gabriella ;

Hueser, Sophia

3 2024 | Surgery. 175(3):605-612

:

BackgroundGastroenteropancreatic neuroendocrine carcinomas (GEP NECs) are rare neoplasms with no effective treatments and poor prognosis. Few reliable...